Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us
Sekisui Diagnostics

Download Mobile App




Inpatient Diagnostic Imaging Improves Outcomes Without Significantly Impacting Costs

By HospiMedica International staff writers
Posted on 23 Nov 2009
Hospitals that make greater use of inpatient diagnostic imaging exams achieve lower in-hospital mortality rates with little or no impact on costs, according to a new study.

The study comprised more than a million patient outcomes in more than 100 hospitals in the United States, the findings of which were published in the November 2009 issue of the Journal of the American College of Radiology (JACR). "The results of our in-depth study would indicate that greater use of imaging does, in fact, lead to better patient outcomes in terms of lower in-hospital death rates with no significant impact on overall cost,” said David W. More...
Lee, Ph.D., lead author of the article and senior director, Health Economics and Outcome Research at GE Healthcare (Chalfont St. Giles, UK). "This study dealt only with imaging provided in hospitals, but would seem to confirm what many have long suspected--that medical imaging exams save lives.”

Researchers examined data from the Thomson Reuters Drug Database (HDD; New York, NY, USA) exploring the association between the utilization of diagnostic imaging services and two key hospital outcome measures: mortality and costs. Their analysis examined data from inpatient admissions that occurred during 2007 in the 102 hospitals in the HDD that provided adequately detailed data to support assessment of the utilization of inpatient diagnostic services. The study included all clinical conditions treated in-hospital, assessing the experience of patients with private, commercial, and governmental-sponsored insurance.

"Because use of imaging procedures grew rapidly in the early parts of this decade, payers and policymakers have questioned whether more diagnostic imaging use is associated with better health outcomes. Based on our research, the answer would appear to be yes,” said Dr. Lee.

Related Links:
GE Healthcare
Thomson Reuters


Gold Member
12-Channel ECG
CM1200B
Radiology Monitor
MDNC-6121 Barco Nio Color 5.8MP
Patient Monitoring System
AlarmSense
Hypodermic Syringe
SurTract™ Safety Syringe
Read the full article by registering today, it's FREE! It's Free!
Register now for FREE to HospiMedica.com and get access to news and events that shape the world of Hospital Medicine.
  • Free digital version edition of HospiMedica International sent by email on regular basis
  • Free print version of HospiMedica International magazine (available only outside USA and Canada).
  • Free and unlimited access to back issues of HospiMedica International in digital format
  • Free HospiMedica International Newsletter sent every week containing the latest news
  • Free breaking news sent via email
  • Free access to Events Calendar
  • Free access to LinkXpress new product services
  • REGISTRATION IS FREE AND EASY!
Click here to Register








Channels

Artificial Intelligence

view channel
Image: Clinical LLM Performance Improves by >300% When Provided with High-Quality Real-World Evidence in New Precision Medicine Benchmark (Photo courtesy of Atropos Health)

New Benchmark Highlights Evidence Gaps in AI Responses to Clinical Questions

Many clinical decisions still rely on limited evidence, while most artificial intelligence benchmarks overlook the patient context that shapes real-world care. General large language models can also struggle... Read more

Critical Care

view channel
Image Credit: 123RF

AI Platform Screens for Amyloid Cardiomyopathy Using ECG Images

Amyloid cardiomyopathy is a heart disease caused by deposits of misfolded proteins in the cardiac muscle. It is often missed until patients develop serious complications such as heart failure.... Read more

Point of Care

view channel
Image Credit: 123RF

Continuous Glucose Monitoring Identifies Cardiometabolic Risk in Adults Without Diabetes

Dysglycemia—abnormal blood glucose regulation—can fluctuate throughout the day and often escape conventional screening. Clinicians typically rely on fasting plasma glucose and hemoglobin A1c, which offer... Read more

Business

view channel
Image: LigaSure RAS Maryland, designed for the Valleylab FT10 platform on Hugo RAS, seals and cuts vessels, tissue, and lymphatics up to 7 mm in diameter (Photo courtesy of Medtronic)

Medtronic Receives FDA Clearance for Vessel-Sealing Instrument for Robotic Surgery

As robotic-assisted surgery expands across U.S. hospitals, teams increasingly seek energy instruments with the familiarity and performance of tools used in open and laparoscopic procedures.... Read more
Copyright © 2000-2026 Globetech Media. All rights reserved.